Endotoxin (LPS) stimulates 4E-BP1/PHAS-I phosphorylation in macrophages

J Surg Res. 2001 May 1;97(1):54-9. doi: 10.1006/jsre.2001.6111.

Abstract

Introduction: Translational control of cytokine production in endotoxin (LPS)-stimulated macrophages is poorly characterized but likely important. An early step in protein translation is engagement of mRNA by eukaryotic initiation factor 4E (eIF-4E). Translation initiation can be prevented by small 4E-binding proteins (4E-BP1 or PHAS-I) which must be phosphorylated in order to disengage eIF-4E. We examined whether LPS alters 4E-BP1 phosphorylation in macrophages.

Materials and methods: Elicited rat peritoneal macrophages and Raw 264.7 macrophages were treated with signal transduction inhibitors and then LPS. Cells were harvested and equal protein amounts were electrophoresed (SDS-PAGE). Western blots (WB) were developed with 4E-BP1 antibody. Alternatively cell lysates were exposed to 7-methyl GTP Sepharose beads in order to isolate the cap-binding protein eIF-4E. The relative amounts of 4E-BP1 associated with eIF-4E were then determined by WB.

Results: Macrophage 4E-BP1 is phosphorylated upon stimulation by LPS as evidenced by the appearance of a more slowly migrating gamma (hyperphosphorylated) band on gel electrophoresis. Inhibition of both the p42/p44 MAPK pathway (PD 98059) and the p38 MAPK pathway (SB 203580) failed to alter LPS-induced 4E-BP1 phosphorylation. Rapamycin (FRAP/mTOR inhibitor) blocked 4E-BP1 phosphorylation causing a predominance of the alpha (hypophosphorylated) band. This was confirmed further by 7-methyl-GTP Sepharose isolation of eIF-4E with which 4E-BP1 coprecipitates.

Conclusion: LPS stimulates 4E-BP1 phosphorylation in macrophages through FRAP/mTOR signaling. This pathway may contribute to the translational control of cytokine gene expression in macrophages.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Carrier Proteins*
  • Cell Line
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology
  • Eukaryotic Initiation Factor-4E
  • Flavonoids / pharmacology
  • Imidazoles / pharmacology
  • Intracellular Signaling Peptides and Proteins
  • Lipopolysaccharides / pharmacology*
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Models, Biological
  • Peptide Initiation Factors / metabolism
  • Phosphoproteins / metabolism*
  • Phosphorylation
  • Protein Biosynthesis
  • Pyridines / pharmacology
  • Rats
  • Sirolimus / pharmacology
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Carrier Proteins
  • Eif4ebp1 protein, rat
  • Enzyme Inhibitors
  • Eukaryotic Initiation Factor-4E
  • Flavonoids
  • Imidazoles
  • Intracellular Signaling Peptides and Proteins
  • Lipopolysaccharides
  • Peptide Initiation Factors
  • Phosphoproteins
  • Pyridines
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Sirolimus